InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Kannan Raj. Officer active across 2 companies, notably CHIASMA, INC. Aggregated, 3 filings have been recorded. History available since 20 December 2021. The latest transaction was disclosed on 21 November 2022 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kannan Raj
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
215,783 股@ US$15.25100.0% 占其流量Common StockSEC:0001209191-22-058154:0
215,783 股0Common StockSEC:0001209191-21-070999:0
137,095 股Common StockSEC:0001209191-21-050025:0
3 条申报中的 3 条
About Kannan Raj
KANNAN RAJ is linked to Aerie Pharmaceuticals INC, where he is Chief Executive Officer, and to CHIASMA, INC, where he is CEO and President. He has 5 filings in total, and in the sampled recent filings the sell volume is EUR 3185290, with a range from 2021-08-05 to 2022-11-21. The modal transaction nature is Disposition.
